# Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients

> **NCT02184286** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 5 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Saquinavir-sgc

## Key facts

- **NCT ID:** NCT02184286
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-05
- **Primary completion:** 2000-02
- **Final completion:** —
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184286, "Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02184286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*